Cinnamon extract lowers glucose, insulin and cholesterol in people with elevated serum glucose

Journal of Traditional and Complementary Medicine

Volumn 6, Issue 4, 2016, Pages 332-336

  Anderson, Richard A ^a   Zhan, Zhiwei ^b   Luo, Rencai ^c   Guo, Xiuhua ^d   Guo, Qingqing ^d   Zhou, Jin ^e   Kong, Jiang ^f   Davis, Paul A ^g   Stoecker, Barbara J ^h  

^a PolyChrom Technology   (United States)

^b Hepatobiliary Gastroenterology Institute   (China)

^c Beijing CDC ^*  (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e Dalian Dakang Clinic   (China)

^f Beijing Tang An Clinic   (China)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Cinnamon; Glucose; Insulin sensitivity; Lipids; Type A procyanidin polyphenols

Indexed keywords

EID: 84992195855     PISSN: None     EISSN: 22254110     Source Type: Journal    
DOI: 10.1016/j.jtcme.2015.03.005     Document Type: Article

References (46)

1. 1 Rao, P.V., Gan, S.H., Cinnamon: a multifaceted medicinal plant. Evid Based Complement Alternat Med, 2014, 2014, 642942.
2. 2 Khan, A., Safdar, M., Ali Khan, M.M., Khattak, K.N., Anderson, R.A., Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26 (2003), 3215–3218.
3. 3 Ziegenfuss, T.N., Hofheins, J.E., Mendel, R.W., Landis, J., Anderson, R.A., Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr 3 (2006), 45–53.
4. 4 Mang, B., Wolters, M., Schmitt, B., et al. Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest 36 (2006), 340–344.
5. 5 Roussel, A.M., Hininger, I., Benaraba, R., Ziegenfuss, T.N., Anderson, R.A., Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. J Am Coll Nutr 28 (2009), 16–21.
6. 6 Solomon, T.P., Blannin, A.K., Effects of short-term cinnamon ingestion on in vivo glucose tolerance. Diabetes Obes Metab 9 (2007), 895–901.
7. 7 Hlebowicz, J., Darwiche, G., Bjorgell, O., Almer, L.O., Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects. Am J Clin Nutr 85 (2007), 1552–1556.
8. 8 Hlebowicz, J., Hlebowicz, A., Lindstedt, S., et al. Effects of 1 and 3 g cinnamon on gastric emptying, satiety, and postprandial blood glucose, insulin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and ghrelin concentrations in healthy subjects. Am J Clin Nutr 89 (2009), 815–821.
9. 9 Crawford, P., Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med 22 (2009), 507–512.
10. 10 Akilen, R., Tsiami, A., Devendra, D., Robinson, N., Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial. Diabet Med 27 (2010), 1159–1167.
11. 11 Vafa, M., Mohammadi, F., Shidfar, F., et al. Effects of cinnamon consumption on glycemic status, lipid profile and body composition in type 2 diabetic patients. Int J Prev Med 3 (2012), 531–536.
12. 12 Magistrelli, A., Chezem, J.C., Effect of ground cinnamon on postprandial blood glucose concentration in normal-weight and obese adults. J Acad Nutr Diet 112 (2012), 1806–1809.
13. 13 Lu, T., Sheng, H., Wu, J., Cheng, Y., Zhu, J., Chen, Y., Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes. Nutr Res 32 (2012), 408–412.
14. 14 Davis, P.A., Yokoyama, W., Cinnamon intake lowers fasting blood glucose: meta-analysis. J Med Food 14 (2011), 884–889.
15. 15 Allen, R.W., Schwartzman, E., Baker, W.L., Coleman, C.I., Phung, O.J., Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med 11 (2013), 452–459.
16. 16 Leach, M.J., Kumar, S., Cinnamon for diabetes mellitus. Cochrane Database Syst Rev, 9, 2012, CD007170.
17. 17 Yang, W., Lu, J., Weng, J., et al. Prevalence of diabetes among men and women in China. N Engl J Med 362 (2010), 1090–1101.
18. 18 World Medical Association Declaration of Helsinki, ethical principles for medical research involving human subjects. JAMA 310 (2013), 2191–2194.
19. 19 Anderson, R.A., Broadhurst, C.L., Polansky, M.M., et al. Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem 52 (2004), 65–70.
20. 20 Broadhurst, C.L., Polansky, M.M., Anderson, R.A., Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. J Agric Food Chem 48 (2000), 849–852.
21. 21 Imparl-Radosevich, J., Deas, S., Polansky, M.M., et al. Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling. Horm Res 50 (1998), 177–182.
22. 22 Jarvill-Taylor, K.J., Anderson, R.A., Graves, D.J., A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes. J Am Coll Nutr 20 (2001), 327–336.
23. 23 Wu, X., Beecher, G.R., Holden, J.M., Haytowitz, D.B., Gebhardt, S.E., Prior, R.L., Lipophilic and hydrophilic antioxidant capacities of common foods in the United States. J Agric Food Chem 52 (2004), 4026–4037.
24. 24 Cao, H., Polansky, M.M., Anderson, R.A., Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch Biochem Biophys 459 (2007), 214–222.
25. 25 Cao, H., Urban, J.F. Jr., Anderson, R.A., Cinnamon polyphenol extract affects immune responses by regulating anti- and proinflammatory and glucose transporter gene expression in mouse macrophages. J Nutr 138 (2008), 833–840.
26. 26 Zhou, B., Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi 23 (2002), 5–10.
27. 27 Wallace, T.M., Levy, J.C., Matthews, D.R., Use and abuse of HOMA modeling. Diabetes Care 27 (2004), 1487–1495.
28. 28 Chan, J.C., Zhang, Y., Ning, G., Diabetes in China: a societal solution for a personal challenge. Lancet Diabetes Endocrinol 2 (2014), 969–979.
29. 29 Hanefeld, M., Ceriello, A., Schwarz, P.E., Bornstein, S.R., The metabolic syndrome–a postprandial disease?. Horm Metab Res 38 (2006), 435–436.
30. 30 Morris, D.H., Khunti, K., Achana, F., et al. Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia 56 (2013), 1489–1493.
31. 31 Engberg, S., Vistisen, D., Lau, C., et al. Progression to impaired glucose regulation and diabetes in the population-based Inter99 study. Diabetes Care 32 (2009), 606–611.
32. 32 Knowler, W.C., Barrett-Connor, E., Fowler, S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002), 393–403.
33. 33 Chiasson, J.L., Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial. Endocr Pract 1:12 suppl (2006), 25–30.
34. 34 DeFronzo, R.A., Tripathy, D., Schwenke, D.C., et al. Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med 364 (2011), 1104–1115.
35. 35 Rabe, K., Lehrke, M., Parhofer, K.G., Broedl, U.C., Adipokines and insulin resistance. Mol Med 14 (2008), 741–751.
36. 36 Dandona, P., Aljada, A., Bandyopadhyay, A., Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25 (2004), 4–7.
37. 37 Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., Garg, R., Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111 (2005), 1448–1454.
38. 38 Esteghamati, A., Khalilzadeh, O., Anvari, M., Ahadi, M.S., Abbasi, M., Rashidi, A., Metabolic syndrome and insulin resistance significantly correlate with body mass index. Arch Med Res 39 (2008), 803–808.
39. 39 Beecher, G.R., Overview of dietary flavonoids: nomenclature, occurrence and intake. J Nutr 133 (2003), 3248S–3254S.
40. 40 Peng, X., Cheng, K.W., Ma, J., et al. Cinnamon bark proanthocyanidins as reactive carbonyl scavengers to prevent the formation of advanced glycation endproducts. J Agric Food Chem 56 (2008), 1907–1911.
41. 41 Cheng, D.M., Kuhn, P., Poulev, A., Rojo, L.E., Lila, M.A., Raskin, I., In vivo and in vitro antidiabetic effects of aqueous cinnamon extract and cinnamon polyphenol-enhanced food matrix. Food Chem 135 (2012), 2994–3002.
42. 42 Gurnell, M., Savage, D.B., Chatterjee, V.K., O'Rahilly, S., The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulation. J Clin Endocrinol Metab 88 (2003), 2412–2421.
43. 43 Mueller, M., Beck, V., Jungbauer, A., PPARalpha activation by culinary herbs and spices. Planta Med 77 (2011), 497–504.
44. 44 Kim, S.H., Choung, S.Y., Antihyperglycemic and antihyperlipidemic action of Cinnamomi Cassiae (Cinnamon bark) extract in C57BL/Ks db/db mice. Arch Pharm Res 33 (2010), 325–333.
45. 45 Qin, B., Panickar, K.S., Anderson, R.A., Cinnamon: potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetes. J Diabetes Sci Technol 4 (2010), 685–693.
46. 46 Qin, B., Dawson, H., Polansky, M.M., Anderson, R.A., Cinnamon extract attenuates TNF-alpha-induced intestinal lipoprotein ApoB48 overproduction by regulating inflammatory, insulin, and lipoprotein pathways in enterocytes. Horm Metab Res 41 (2009), 516–522.